Results

Total Results: 2,005 records

Showing results for "adverse".

41. Comparative Effectiveness Review No. 266_Cervical Degenerative Disease Treatment: A Systematic Review (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-266-cdd-executive-summary.pdf
    November 01, 2023 - with radiculopathy and 1-level disease (SOE: Low), but the likelihood of experiencing any serious adverse … (SOE) Pain; Effect (SOE) Function; Effect (SOE) Quality of Life; Effect (SOE) Adverse … (SOE) Pain; Effect (SOE) Function; Effect (SOE) Quality of Life; Effect (SOE) Adverse … However, there were some differences in the frequency of adverse events for some comparisons. … Limited evidence also suggests a lower likelihood of experiencing any serious adverse event with ACDF

42. Dia 1 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/ijzerman_ahrq-webinar-mcda.pdf
    January 01, 2011 - I want the best treatment: Clinical Outcome symptom relief partial relief partial relief Adverse … Events high blood pressure high blood pressure No adverse events Out-of-Pocket Costs 5 US$ … Events high blood pressure high blood pressure No adverse events Out-of-Pocket Costs 5 US$ … events Response Remission No relapse Efficacy Sexual dysfunction Other adverse … events Disease specific QoL Adverse events Serious adverse events Adverse events Prioritize

43. Adverse Effects of First-line Pharmacologic Treatments of Major Depression in Older Adults | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/depression-harms/research-protocol
    May 01, 2019 - We replaced the term "harms" with "adverse effects" based on input from the KI panel suggesting that … adverse effects of first-line pharmacologic treatments? … effects and comparative adverse effects of first-line pharmacologic treatments? … Outcomes: We are interested in the following adverse effects for KQ1 and KQ2: Any adverse event, … as in those who experienced an adverse events Withdrawal due to adverse events Serious adverse events

44. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
    January 30, 2020 - The current CTCAE system (version 5) differentiates 837 adverse events within 26 adverse event domains … adverse events The appraisal of the data collection method will evaluate the rigor of the adverse … The reporting appraisal will assess whether adverse events, including serious adverse events, were defined … Common Terminology Criteria for Adverse Events classification system (CTCAE) adverse event domains … Common Terminology Criteria for Adverse Events classification system (CTCAE) adverse event domains

45. Treatments for Fecal Incontinence: Current State of the Evidence | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/fecal-incontinence/clinician
    December 01, 2019 - This is a summary of a systematic review evaluating the evidence regarding the potential benefits and adverse … Noninvasive nonsurgical fecal incontinence treatments had few minor adverse effects. … Access the full report for detailed findings on the comparative effectiveness and adverse effects … Most Common Adverse Effects FDA = U.S. … Substantial and lifealtering adverse events sometimes occur after surgery for fecal incontinence, and

46. Effectiveness and Safety of Antiepileptic Medications in Patients With Epilepsy | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/epilepsy-medicine/research
    December 01, 2019 - The risk of withdrawing due to adverse events and the risk of several adverse events including fatigue … receiving carbamazepine sustained or controlled release products but are more likely to withdraw due to adverse … The risk of certain adverse events including fatigue, somnolence, nausea, and alopecia were significantly … and phenytoin provided epilepsy control similar to newer antiepileptic medications, but there were adverse … However, these adverse events did not significantly increase the risk of withdrawals.

47. Depression in Children: Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/childhood-depression/protocol
    October 01, 2020 - *:ti,ab or "adverse outcome":ti,ab or "adverse outcomes":ti,ab or [mh "Adverse Drug Reaction Reporting … Effects" OR TX “adverse effect” or TX “adverse event” OR TX “adverse events” OR TX "adverse outcome" … OR TX "adverse outcomes" OR TX “adverse reaction” OR TX “adverse reactions” OR TX “chemically induced … *:ti,ab or "adverse outcome":ti,ab or "adverse outcomes":ti,ab or [mh "Adverse Drug Reaction Reporting … Effects" OR TX “adverse effect” or TX “adverse event” OR TX “adverse events” OR TX "adverse outcome"

48. Topic 0549 Diagnosis and Management of Gout NSD _SJ Clean (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0648-140819.pdf
    June 24, 2014 - Outcome(s): Health outcomes (e.g. mortality, morbidity, adverse events), functional status, patient … Does the risk of adverse effects differ according to patient baseline diet and fluid intake? c. … Does the risk of adverse effects differ according to joint vs. systemic involvement in gout? … Does the risk of adverse effects differ according to patient baseline diet and fluid intake? c. … Does the risk of adverse effects differ according to characteristics of (joint/ gout/systemic) In

49. Peripheral Artery Disease (PAD) - defined as peripheral artery disease of the lower extremities 1) Does aspirin reduce the risk of adverse cardiovascular events (MI, stroke, cardiovascular death) in patients with PAD? Is there a… | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/peripheral-artery-disease-pad-defined-as-peripheral-artery-disease-of-the-lower-extremities-1-does-aspirin-reduce-the-risk-of-adverse-cardiovascular-events-mi-stroke-cardiovascular-death-in-patients-with-pad-is-there-a-diffe
    November 01, 2017 - - defined as peripheral artery disease of the lower extremities 1) Does aspirin reduce the risk of adverse … - defined as peripheral artery disease of the lower extremities 1) Does aspirin reduce the risk of adverse … defined as peripheral artery disease of the lower extremities Does aspirin reduce the risk of adverse … Is clopidogrel more effective than aspirin in reducing adverse cardiovascular events in PAD? … It is associated with a 5 fold increased risk of adverse cardiovascular events.

50. Nonpharmacological Versus Pharmacological Treatment for Patients With Major Depressive Disorder: Current State of the Evidence (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_clinician.pdf
    September 01, 2016 - is a summary of a systematic review evaluating the evidence regarding the comparative benefits and adverse … evidence suggests that there is a trend toward a higher rate of treatment discontinuation due to adverse … with SGAs. �� The evidence is also insufficient to permit conclusions about differences in serious adverse … Overview of Clinical Research Evidence (Continued) Table 4: Common Adverse Effects Reported in Studies … effects associated with MDD treatments, including the potential serious adverse effects associated

51. App-E-Surv-Report-3-Acute-Pain (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-acute-pain.xlsx
    September 21, 2022 - Events Adverse Events Withdrawals Due to Adverse Events Sponsor Quality Skonnord, 2020 Outpatient Norway … Events Adverse Events Withdrawals Due to Adverse Events Sponsor Quality Akgol Gur, 2020 Emergency department … Events Adverse Events Withdrawals Due to Adverse Events Sponsor Quality Bloom, 2021 Postoperative to … Events Adverse Events Withdrawals Due to Adverse Events Sponsor Quality Cooper, 2021 Outpatient U.S … B Any adverse event: 52.7% (15/36) vs. 8.8% (3/34), p=0.002 Any severe adverse event: 16.7% (6/36) vs

52. App-E-Surv-Report-2-Acute-Pain (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-acute-pain.xlsx
    September 20, 2022 - Events Adverse Events Withdrawals Due to Adverse Events Sponsor Quality Skonnord, 2020 Outpatient Norway … Events Adverse Events Withdrawals Due to Adverse Events Sponsor Quality Akgol Gur, 2020 Emergency department … Events Adverse Events Withdrawals Due to Adverse Events Sponsor Quality Bloom, 2021 Postoperative to … Events Adverse Events Withdrawals Due To Adverse Events Sponsor Quality Cooper, 2021 Outpatient U.S … B Any adverse event: 52.7% (15/46) vs. 8.8% (3/34), p=0.002 Any severe adverse event: 16.7% (6/36) vs

53. Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
    January 01, 2011 - set of criteria (attributes and levels): • I want the best treatment: Clinical Outcome Adverse … Drug B partial relief high blood pressure 3 US$ Drug C partial relief No adverse … preference for the alternatives: • I want the best treatment: Clinical Outcome C1 = 0.5 Adverse … events points to: • Serious adverse events, which points to : o Suicide and attempted suicide o … Other serious adverse events • Adverse events, which points to: o Sexual dysfunction o Other adverse

54. Comparative Effectiveness of First and Second Generation Antipsychotics in the Pediatric and Young Adult Populations | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/antipsychotics-children/research-protocol
    December 01, 2019 - This includes: Overall adverse events Specific adverse events Withdrawals/time to withdrawal … events, withdrawal due to adverse events, persistence and reversibility of adverse events. … events, specific events, withdrawals due to adverse events, time to withdrawal due to adverse events … Adverse events will be recorded for each intervention group including the description of the adverse … dose-adverse event analysis.

55. Migraine in Adults: Preventive Pharmacologic Treatments | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/migraine-prevention/research-2013
    December 01, 2019 - effects, and 26 (95% CI, 10 to 43) would discontinue treatments due to bothersome adverse effects. … Adverse effects leading to treatment discontinuation were examined in 68 RCTs. … effects and treatment discontinuation due to adverse effects. … For episodic migraine, approved drugs are effective but increase risk of adverse effects and treatment … discontinuation due to adverse effects.

56. Major-Depressive-Disorder Executive (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/major-depressive-disorder_executive.pdf
    December 01, 2015 - events, withdrawals because of adverse events, serious adverse events, specific adverse events (including … because of adverse events. … of adverse events. … events, overall risk of serious adverse events, or discontinuation due to adverse events. … events, overall risk of serious adverse events, or discontinuation due to adverse events.

57. Nonsurgical Treatments for Urinary Incontinence in Women: A Systematic Review Update | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/urinary-incontinence-update/final-report-2018
    July 01, 2020 - Serious adverse events are rare for all interventions. … We included UI outcomes (cure, improvement, satisfaction), quality of life, and adverse events. … Quality of life and adverse event outcomes are narratively described. Results. … Constitutional adverse events (e.g., nausea, insomnia, fatigue) were common with duloxetine (moderate … Common adverse events with pharmacological treatments include dry mouth, nausea, and fatigue.

58. Adverse Effects of First-Line Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ehc-depression-research-protocol.pdf
    February 07, 2018 - adverse effects of first-line pharmacologic treatments? … effects and comparative adverse effects of first-line pharmacologic treatments? … Outcomes: We are interested in the following adverse effects for KQ1 and KQ2: • Any adverse event … , as in those who experienced an adverse events • Withdrawal due to adverse events • Serious adverse … Effects • Adverse events • Withdrawal due to adverse events • Serious adverse events • Hospitalization

59. Cervical Degenerative Disease Treatment: A Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/cervical-degenerative-disease/research
    February 01, 2024 - However, there were some differences in the frequency of adverse events for some comparisons. … However, there were some differences in the frequency of adverse events for some comparisons. … Limited evidence also suggests a lower likelihood of experiencing any serious adverse event with ACDF … ACDF = anterior cervical discectomy and fusion; AE = adverse event; BMP-2 = bone morphogenetic protein … The likelihood of general or specific adverse events, such as need for reoperation/revision surgery,

60. Research Protocol: Radiation Therapy for Brain Metastases (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
    October 10, 2019 - The broader inclusion criteria for adverse event data take into account that rare adverse events are … adverse events The appraisal of the data collection method will evaluate the rigor of the adverse … The reporting will also assess whether adverse events, including serious adverse events, were defined … Number of patients with serious adverse events 2. Number of adverse events 3. … What is a Serious Adverse Event?